Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes

Multiple Sclerosis Journal

Volumn 19, Issue 8, 2013, Pages 1035-1045

  Satoh, Jun Ichi ^a   Tabunoki, Hiroko ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

ChIP Seq; GenomeJack; multiple sclerosis; pathway analysis; VDR; vitamin D

Indexed keywords

CALCITRIOL; FC RECEPTOR; TRANSCRIPTOME; VITAMIN D;

ARTICLE; B LYMPHOCYTE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; GENOME; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INTRON; LEUKOCYTE; MONOCYTE; NEUROPROTECTION; PHAGOCYTOSIS; PROMOTER REGION; TRANSCRIPTION INITIATION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; UPREGULATION; VITAMIN D RECEPTOR GENE;

EID: 84879768723     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512471873     Document Type: Article

References (34)

1. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 2010 ; 9: 599-612
2. Wang TT, Tavera-Mendoza LE, Laperriere D, et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 ; 19: 2685-2695 (Pubitemid 41577243)
3. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009 ; 5: e1000369
4. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 ; 296: 2832-2838 (Pubitemid 44969183)
5. Smolders J, Thewissen M, Peelen E, et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One. 2009 ; 4: e6635
6. Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009 ; 183: 5458-5467
7. Hanwell HE, Banwell B. Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim Biophys Acta. 2011 ; 1812: 202-212
8. Baranzini SE, Mudge J, van Velkinburgh JC, et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature. 2010 ; 464: 1351-1356
9. Park PJ. ChIP-seq: Advantages and challenges of a maturing technology. Nat Rev Genet. 2009 ; 10: 669-680
10. Satoh JI, Tabunoki H, Yamamura T. Molecular network of the comprehensive multiple sclerosis brain-lesion proteome. Mult Scler. 2009 ; 15: 531-541
11. Romme Christensen J, Börnsen L, Hesse D, et al. Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis. J Neuroinflammation. 2012 ; 9: 215
12. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010 ; 20: 1352-1360
13. Heikkinen S, Väisänen S, Pehkonen P, et al. Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 2011 ; 39: 9181-9193
14. Fairfax BP, Makino S, Radhakrishnan J, et al. Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nat Genet. 2012 ; 44: 502-510
15. Carlberg C, Seuter S, Heikkinen S. The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res. 2012 ; 32: 271-282
16. Landt SG, Marinov GK, Kundaje A, et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 2012 ; 22: 1813-1831
17. Pike JW, Meyer MB, Martowicz ML, et al. Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 2010 ; 121: 130-135
18. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev. 2008 ; 29: 726-776
19. Meyer MB, Goetsch PD, Pike JW. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J Steroid Biochem Mol Biol. 2010 ; 121: 136-141
20. Kim S, Yamazaki M, Zella LA, et al. Activation of receptor activator of NF-κB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol Cell Biol. 2006 ; 26: 6469-6486 (Pubitemid 44277887)
21. Fleet JC, DeSmet M, Johnson R, et al. Vitamin D and cancer: A review of molecular mechanisms. Biochem J. 2012 ; 441: 61-76
22. Lickwar CR, Mueller F, Hanlon SE, et al. Genome-wide protein-DNA binding dynamics suggest a molecular clutch for transcription factor function. Nature. 2012 ; 484: 251-255
23. Disanto G, Sandve GK, Berlanga-Taylor AJ, et al. Vitamin D receptor binding, chromatin states and association with multiple sclerosis. Hum Mol Genet. 2012 ; 21: 3575-3586
24. Pedersen LB, Nashold FE, Spach KM, et al. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res. 2007 ; 85: 2480-2490 (Pubitemid 47204762)
25. Manes TD, Pober JS. Identification of endothelial cell junctional proteins and lymphocyte receptors involved in transendothelial migration of human effector memory CD4+ T cells. J Immunol. 2011 ; 186: 1763-1768
26. Von Essen MR, Kongsbak M, Schjerling P, et al. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 2010 ; 11: 344-349
27. Satoh J, Nakanishi M, Koike F, et al. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol Dis. 2005 ; 18: 537-550 (Pubitemid 40332713)
28. Klunker S, Chong MM, Mantel PY, et al. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med. 2009 ; 206: 2701-2715
29. Banchereau J, Pascual V, O'Garra A. From IL-2 to IL-37: The expanding spectrum of anti-inflammatory cytokines. Nat Immunol. 2012 ; 13: 925-931
30. Disanto G, Morahan JM, Barnett MH, et al. The evidence for a role of B cells in multiple sclerosis. Neurology. 2012 ; 78: 823-832
31. Krumbholz M, Theil D, Cepok S, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain. 2006 ; 129: 200-211 (Pubitemid 43063771)
32. Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002 ; 8: 500-508 (Pubitemid 34546753)
33. Massol P, Montcourrier P, Guillemot JC, et al. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J. 1998 ; 17: 6219-6229 (Pubitemid 28497795)
34. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25- dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004 ; 173: 2909-2912 (Pubitemid 39141992) Technology